Roivant Sciences Ltd. · NASDAQ:ROIV
Gline Matthew sold 289,774 Roivant Sciences Ltd. shares (Form 4)
Traded Apr 16, 2026 · Filed Apr 20, 2026
On Apr 16, 2026, Gline Matthew (Director, CEO) sold 289,774 Roivant Sciences Ltd. shares at US$29.16 for US$8.45M, leaving 16,736,116 shares. Filed Apr 20, 2026 (Form 4).
- Sold
- 289,774 shares
- Price
- US$29.16
- Value
- US$8.45M
- Holding after
- 16,736,116 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Shares | Sale | 289,774 | US$29.16 | 16,736,116 | Direct |
Source
Related
- Roivant Sciences Ltd.
- Gline Matthew
- Roivant Sciences Ltd. shareholders
- Form 4 · Gline Matthew · Oct 2, 2026
- Form 4 · Gline Matthew · Jul 2, 2026
- Form 4 · Gline Matthew · Apr 1, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Sukhatme Mayukh · Oct 2, 2026
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026
- Form 4 · Pulik Richard · Sep 22, 2026